[June 24, 2009]
How to Strengthen Capacity in Africa for the Registration of New Drugs for Neglected Diseases? That was the topic discussed by more than 50 attendees at the workshop which was held during DNDi‘s 2nd Stakeholders’ and 3rd African Meetings, in Nairobi, Kenya.
The workshop looked into present regulatory approaches and mechanisms, how they interact with each other and what are the advantages and disadvantages of each in supporting the registration process in Africa. Several case studies with different registration strategies were presented to inform the broader discussion. The workshop’s aim was to identify the best regulatory approach to enable, in Africa, the registration of new chemical entities.